BMG Pharma Announces the Acquisition of a Fully Patented Technology
Platform and Creates New Company with Product Development Experts

July 11, 2018 09:00 AM Eastern Daylight Time

MILAN--(BUSINESS WIRE)--BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is
pleased to announce the creation of a new company (named BMG Pharma
S.p.A.) with Sigea S.r.l, an Italian company with expertise in targeted
research and development of functional ingredients development currently
focused on modified polysaccharides for application in a number of
therapeutic areas including aesthetic dermatology, osteoarthritis and
oral care.

Sigea was founded in 1996 following a spin-off from a cooperative
research company, Polytech SCaRL, and is located in AREA Science Park of
Padriciano (TS) . It employs a number of scientists with key skills in
synthetic, analytical, biological chemistry and in development of
functional ingredients in the field of cosmetics and medical devices who
have already demonstrated a strong product development capability with a
number of key partnerships.

The new company will give BMG the opportunity to rapidly complete the
development of a number of new patent protected products with topical
and subcutaneous applications, which it will be able to offer to its
network of global marketing partners for the benefit of patients
globally.

Marco Mastrodonato, formerly CEO of BMG Pharma S.r.l.&
Roberto Bianchi , President of Sigea S.r.l now CEO and Chairman of the
Board of BMG Pharma S.p.A., commented– “This is an important step for
the companies and represents a significant growth opportunity by
creating a new team with improved capabilities already focused in
product innovation, regulatory expertise and commercial partnering and
the new pipeline will allow the company to develop unique propositions
in topical and injectable areas of applications.

About BMG Pharma S.p.A.

BMG Pharma S.p.A. is a specialty pharmaceutical company with its head
office in Milan, Italy, leveraging its proprietary technology to develop
products that address unmet needs for patients. The Company is currently
focused on partnering its product portfolio in dermatology, oral / nasal
care, anaemia, gynaecology, aesthetics, osteoarthritis and cancer
supportive care. BMG Pharma S.p.A. is dedicated to helping pharma
companies in providing valuable and innovative products to patients,
pharmacists and physicians.